Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Veliparib and Temozolomide in Solid Tumors (Extension Study)
NCT01193140Phase 2Completed
- Sponsor
- Abbott Laboratories
- Start
- Jul 2010
- Primary completion
- Nov 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of veliparib in solid tumor, sponsored by Abbott Laboratories. Started Jul 2010; status: completed.
02
Drugs
veliparib
03
Conditions
solid tumor
Beyond the preview
Go deeper on NCT01193140.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01193140.